Highlight Therapeutics y Pivotal trabajan conjuntamente en el tratamiento del melanoma y lanzan un ensayo clínico fase IIa para determinar la seguridad y eficacia de BO-112

by Pivotal

Highlight Therapeutics,(“Highlight”), una compañía biofarmacéutica clínica que desarrolla tratamientos antitumorales basados en RNA, y Pivotal, una CRO de implantación Europea y que ofrece se...

Read more

Pivotal to collaborate with Checkpoint Therapeutics on a study in patients with cutaneous squamous cell carcinoma​

by Pivotal

Pivotal announced today that it has been contracted by Checkpoint Th​erapeutics Inc., a New York City-based biotechnology company, to provide expert clinical research services in Europe for its upco...

Read more

Highlight Therapeutics & Pivotal advance into a Phase IIa trial to examine Gastro-Intestinal cancer therapy

by Pivotal

Highlight Ther​apeutics, (“Highlight”), a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, and Pivotal, a Europe-wide full-service CRO, today announced tha...

Read more

Staidson and Pivotal are collaborating in the conduct of a clinical trial in Europe in severe COVID-19 patients

by Pivotal

Staid​son, a biopharmaceutical company developing investigational products by targeting the complement system and Pivotal, a European-wide full-service CRO, headquartered in Madrid, have announced t...

Read more

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer

by Pivotal

​Pivotal, a specialist CRO, has been awarded two clinical trials for a novel investigational immunotherapy drug and patient enrolment has now started. Pivotal will use its deep knowledge of Oncology...

Read more

Pivotal´s milestone in the European Society for Medical Oncology Congress

by Pivotal

On Tuesday, October 23rd, the European Society for Medical Oncology Congress (ESMO) ended its annual Congress in Munich with over 26,000 oncology professionals from all over the world. This congress w...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

VHIO ‘on the ground’ at ESMO 2021: r...

by VHIO

During this week’s virtual 2021 Annual Congress of the European Soci...

Photos Stream